Osaic Holdings’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Osaic Holdings’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,392	Closed	-$68K	–	7771
2021 Q3	$68K	Buy	3,392 +648	+24%	+$17.9K	﹤0.01%	4872
2021 Q2	$101K	Buy	2,744 +1,287	+88%	+$39.4K	﹤0.01%	4478
2021 Q1	$37K	Buy	1,457 +407	+39%	+$10.4K	﹤0.01%	5099
2020 Q4	$23K	Hold	1,050	–	–	﹤0.01%	5087
2020 Q3	$20K	Sell	1,050 -108	-9%	-$2.24K	﹤0.01%	4924
2020 Q2	$29K	Sell	1,158 -17	-1%	-$366	﹤0.01%	4570
2020 Q1	$22K	Buy	+1,175	New	+$22.8K	﹤0.01%	4589

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Osaic Holdings's DRNA Position: Q4 2021 in Review

Osaic Holdings sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 3,392 shares — an estimated $68K sold.

Osaic Holdings first reported a position in DRNA in Q1 2020 and held it in 7 quarters. The position peaked at $101K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Osaic Holdings reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Osaic Holdings sold 3,392 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $68K.
Osaic Holdings first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2020 and held it in 7 quarters.
Osaic Holdings's Dicerna Pharmaceuticals, Inc. position peaked at $101K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Osaic Holdings's 13F filing for Q4 2021, filed 3 Feb 2022.